 The purpose of this study is to compare once a week and once every other week darbepoetin alfa on the change in hemoglobin levels between the screeningbaseline period and the evaluation period weeks 25-30. This study will also assess the change in mean hemoglobin over 4 week intervals, instability of hemoglobin concentrations, darbepoetin alfa dosing requirements and red blood cell transfusions. 